Now Is The Time For Universal Health Care
The Medicare End-Stage Renal Disease (ESRD) Program is one of the most significant developments in the history of U.S. health care and an unqualified success.
Commentary
Funding Prostate Cancer Prevention Efforts
The risk of a man’s developing prostate cancer is approximately 18%. Whereas it has been estimated that as much as 60% of this risk is due to environmental exposure (J Urol. 2007;178:S9-S13), developing strategies to mitigate this risk is an important public heath concern.
Important Lessons from ONTARGET
In the past year, an important landmark study demonstrated therapeutic equivalence of the ACE inhibitor ramipril and the angiotensin receptor blocker (ARB) telmisartan in reducing the risk of all forms of atherosclerotic events.
Taking on the Issue of Transplant Tourism
As the U.S. waiting list for kidney transplants grows, and with it the potential for longer waiting times, so might the temptation among end-stage renal disease patients to travel abroad for a transplant.
The Need for Renal & Urology News
A highly respected senior nephrologist and renowned opinion leader, who also happened to be my good old friend and colleague, asked me why I and some other academicians are involved in supporting such non-peer-reviewed journals as Renal & Urology News (RUN).
Marketing Donor Kidneys: A Personal Viewpoint
In mid-July 2008, 90,000 Americans were listed by the Organ Procurement and Transplant Network (OPTN) as waiting for a deceased donor kidney.
The Challenges of Nephrology Research
Nephrologists want to improve outcomes and quality of life for renal disease patients through research, but we are faced with major hurdles.
Urine Test Detects Upper Tract TCC
With upper tract transitional cell carcinoma (UTTCC), vigilance is the watchword. Detecting this cancer earlier may directly impact patient survival. According to the American Cancer Society, 54,390 new cases and 14,100 deaths in the United States will occur during 2008.
CKD: Speaking the Same Language
Decreases in glomerular filtration rate (GFR) are associated with higher risks of cardiovascular events, hospitalizations, and premature death (N Engl J Med. 2004;351:1296-1305).
In Clinical Trials, Does One Size Fit All?
Practicing evidence-based medicine can be difficult in nephrology, where randomized controlled trials are few and far between. In general, the more that trials use hard outcomes such as morbidity and mortality, the greater our confidence that the therapies will have an impact on patients’ lives. Using end points such as these, however, often require large sample sizes.
- Loading...
Loading...
Next post in Commentary
Loading... 
Loading...